ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,540,000 | -75.4% | 375,546 | -78.6% | 0.02% | -74.6% |
Q4 2021 | $6,266,000 | +97.2% | 1,755,300 | +101.1% | 0.06% | +96.9% |
Q3 2021 | $3,178,000 | +124.8% | 872,976 | +169.3% | 0.03% | +146.2% |
Q2 2021 | $1,414,000 | +85.1% | 324,222 | +74.4% | 0.01% | +85.7% |
Q1 2021 | $764,000 | +1.6% | 185,895 | -1.4% | 0.01% | -36.4% |
Q4 2020 | $752,000 | +52.8% | 188,577 | +3.6% | 0.01% | +22.2% |
Q3 2020 | $492,000 | +85.7% | 182,106 | +89.3% | 0.01% | +12.5% |
Q2 2020 | $265,000 | +43.2% | 96,224 | +22.5% | 0.01% | +100.0% |
Q1 2020 | $185,000 | – | 78,580 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |